{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:04:24Z","timestamp":1793765064078,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T00:00:00Z","timestamp":1407456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00259-014-2871-y","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T08:44:25Z","timestamp":1407401065000},"page":"2232-2241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of 11C-choline PET\/CT for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract: a pilot study"],"prefix":"10.1007","volume":"41","author":[{"given":"Naoto","family":"Sassa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Iwano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokunori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momokazu","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Naganawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,8]]},"reference":[{"key":"2871_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"2871_CR2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005. BJU Int. 2011;107(7):1059\u201364.","journal-title":"BJU Int"},{"key":"2871_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semnuclmed.2004.06.004","volume":"34","author":"H Sch\u00f6der","year":"2004","unstructured":"Sch\u00f6der H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004;34:274\u201392.","journal-title":"Semin Nucl Med"},{"key":"2871_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.semnuclmed.2005.09.001","volume":"36","author":"S Jana","year":"2006","unstructured":"Jana S, Blaufox MD. Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med. 2006;36:51\u201372.","journal-title":"Semin Nucl Med"},{"key":"2871_CR5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1464-410X.2010.09212.x","volume":"106","author":"M Lodde","year":"2010","unstructured":"Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y. Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int. 2010;106:658\u201363.","journal-title":"BJU Int"},{"key":"2871_CR6","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1200\/JCO.2008.20.6722","volume":"27","author":"AS Kibel","year":"2009","unstructured":"Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography\/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol. 2009;27:4314\u201320.","journal-title":"J Clin Oncol"},{"key":"2871_CR7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eururo.2009.05.014","volume":"57","author":"G Swinnen","year":"2010","unstructured":"Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, et al. FDG-PET\/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol. 2010;57:641\u20137.","journal-title":"Eur Urol"},{"key":"2871_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2007.03.032","volume":"52","author":"V Scattoni","year":"2007","unstructured":"Scattoni V, Picchio M, Suardi N, Messa C, Freschi M, Roscigno M, et al. Detection of lymph-node metastases with integrated [11C]choline PET\/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol. 2007;52:423\u20139.","journal-title":"Eur Urol"},{"key":"2871_CR9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1464-410X.2008.07592.x","volume":"102","author":"D Schilling","year":"2008","unstructured":"Schilling D, Schlemmer HP, Wagner PH, B\u00f6ttcher P, Merseburger AS, Aschoff P, et al. Histological verification of 11C-choline-positron emission\/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int. 2008;102:446\u201351.","journal-title":"BJU Int"},{"key":"2871_CR10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000296298","volume":"84","author":"A Winter","year":"2010","unstructured":"Winter A, Uphoff J, Henke RP, Wawroschek F. First results of [11C] choline PET\/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy. Urol Int. 2010;84:418\u201323.","journal-title":"Urol Int"},{"key":"2871_CR11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.juro.2010.04.084","volume":"184","author":"G Giovacchini","year":"2010","unstructured":"Giovacchini G, Picchio M, Briganti A, Cozzarini C, Scattoni V, Salonia A, et al. [11C]choline positron emission tomography\/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging. J Urol. 2010;184:938\u201343.","journal-title":"J Urol"},{"key":"2871_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eururo.2011.01.015","volume":"60","author":"T Budiharto","year":"2011","unstructured":"Budiharto T, Joniau S, Lerut E, Van den Bergh L, Mottaghy F, Deroose CM, et al. Prospective evaluation of 11C-choline positron emission tomography\/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases. Eur Urol. 2011;60:125\u201330.","journal-title":"Eur Urol"},{"key":"2871_CR13","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1158\/1078-0432.CCR-11-2048","volume":"17","author":"K Contractor","year":"2011","unstructured":"Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, et al. Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression. Clin Cancer Res. 2011;17:7673\u201383.","journal-title":"Clin Cancer Res"},{"key":"2871_CR14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2011.07.060","volume":"60","author":"P Rigatti","year":"2011","unstructured":"Rigatti P, Suardi N, Briganti A, Da Pozzo LF, Tutolo M, Villa L, et al. Pelvic\/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography\/computed tomography. Eur Urol. 2011;60:935\u201343.","journal-title":"Eur Urol"},{"key":"2871_CR15","doi-asserted-by":"crossref","first-page":"601572","DOI":"10.1155\/2012\/601572","volume":"2012","author":"T Martini","year":"2012","unstructured":"Martini T, Mayr R, Trenti E, Palermo S, Comploj E, Pycha A, et al. The role of C-choline-PET\/CT-guided secondary lymphadenectomy in patients with PSA failure after radical prostatectomy: lessons learned from eight cases. Adv Urol. 2012;2012:601572.","journal-title":"Adv Urol"},{"key":"2871_CR16","first-page":"1642","volume":"46","author":"M Farsad","year":"2005","unstructured":"Farsad M, Schiavina R, Castellucci P, Nanni C, Corti B, Martorana G, et al. Detection and localization of prostate cancer: correlation of (11)C-choline PET\/CT with histopathologic step-section analysis. J Nucl Med. 2005;46:1642\u20139.","journal-title":"J Nucl Med"},{"key":"2871_CR17","first-page":"1249","volume":"47","author":"SN Reske","year":"2006","unstructured":"Reske SN, Blumstein NM, Neumaier B, Gottfried HW, Finsterbusch F, Kocot D, et al. Imaging prostate cancer with 11C-choline PET\/CT. J Nucl Med. 2006;47:1249\u201354.","journal-title":"J Nucl Med"},{"key":"2871_CR18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.juro.2006.04.015","volume":"176","author":"G Martorana","year":"2006","unstructured":"Martorana G, Schiavina R, Corti B, Farsad M, Salizzoni E, Brunocilla E, et al. 11C-choline positron emission tomography\/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. J Urol. 2006;176:954\u201360.","journal-title":"J Urol"},{"key":"2871_CR19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1148\/radiol.2443061063","volume":"244","author":"C Testa","year":"2007","unstructured":"Testa C, Schiavina R, Lodi R, Salizzoni E, Corti B, Farsad M, et al. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET\/CT. Radiology. 2007;244:797\u2013806.","journal-title":"Radiology"},{"key":"2871_CR20","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.ejrad.2010.07.023","volume":"80","author":"C Fuccio","year":"2011","unstructured":"Fuccio C, Rubello D, Castellucci P, Marzola MC, Fanti S. Choline PET\/CT for prostate cancer: main clinical applications. Eur J Radiol. 2011;80:e50\u20136.","journal-title":"Eur J Radiol"},{"key":"2871_CR21","doi-asserted-by":"crossref","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumors. Urological tumors. 7 ed revised. New York, NY: Wiley-Blackwell; 2009. p. 258\u201361","DOI":"10.1002\/9780471420194.tnmc38"},{"key":"2871_CR22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cncr.26238","volume":"118","author":"E Scosyrev","year":"2012","unstructured":"Scosyrev E, Messing EM, van Wijngaarden E, Peterson DR, Sahasrabudhe D, Golijanin D, et al. Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder. Cancer. 2012;118:72\u201381.","journal-title":"Cancer"},{"key":"2871_CR23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.eururo.2011.12.010","volume":"61","author":"R Rosenblatt","year":"2012","unstructured":"Rosenblatt R, Sherif A, Rintala E, Wahlqvist R, Ull\u00e9n A, Nilsson S, et al. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer. Eur Urol. 2012;61:1229\u201338.","journal-title":"Eur Urol"},{"key":"2871_CR24","unstructured":"Suter G, Algava F, Amin MB, Busch C, Cheville J, Gasser T, et al. Tumors of the urinary system. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004. p. 110\u201323."},{"key":"2871_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0b013e3283418057","volume":"23","author":"A Khosroshahi","year":"2011","unstructured":"Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:57\u201366.","journal-title":"Curr Opin Rheumatol"},{"key":"2871_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1\u201314.","journal-title":"Mod Rheumatol"},{"key":"2871_CR27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/MCB.9.1.325","volume":"9","author":"IG Macara","year":"1989","unstructured":"Macara IG. Elevated phosphocholine concentration in ras-transformed NIH 3\u00a0T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown. Mol Cell Biol. 1989;9:325\u20138.","journal-title":"Mol Cell Biol"},{"key":"2871_CR28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/abbi.1995.9959","volume":"323","author":"S Ratnam","year":"1995","unstructured":"Ratnam S, Kent C. Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. Arch Biochem Biophys. 1995;323:313\u201322.","journal-title":"Arch Biochem Biophys"},{"key":"2871_CR29","first-page":"1375","volume":"16","author":"R Katz-Brull","year":"1996","unstructured":"Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res. 1996;16:1375\u201380.","journal-title":"Anticancer Res"},{"key":"2871_CR30","first-page":"3599","volume":"61","author":"E Ackerstaff","year":"2001","unstructured":"Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res. 2001;61:3599\u2013603.","journal-title":"Cancer Res"},{"key":"2871_CR31","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00259-002-0881-7","volume":"29","author":"IJ Jong de","year":"2002","unstructured":"de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience. Eur J Nucl Med Mol Imaging. 2002;29:1283\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-014-2871-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2871-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2871-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:50:35Z","timestamp":1717203035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-014-2871-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,8]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2871"],"URL":"https:\/\/doi.org\/10.1007\/s00259-014-2871-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,8]]}}}